Found 32 matching trials
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma PHASE2 The purpose of this study is to test see the combined effects of the study ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma PHASE2 RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma PHASE2 The purpose of this study is to find out what effect an antibody called Hum...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Los Angeles (Data Collection Only)
Learn More & Join Trial
Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma PHASE1 RATIONALE: Biological therapies such as beta-glucan use different ways to s...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors PHASE1 The purpose of this study is to find out if "humanized 3F8" (Hu3F8) when co...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma PHASE2 This is an prospective study to evaluate the safety and efficacy of naxitam...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE1 This is a safety / feasibility trial evaluating the combination of a humani...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma PHASE2 A six courses regimen consisting of a 8 hour infusion (ch14.18/CHOmAb 20 mg...
Show More Location
University Hospital Graz
Learn More & Join Trial
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow PHASE2 Children and adults diagnosed with high-risk neuroblastoma patients with pr...
Show More Status
Active Not Recruiting
Location
Riley Hospital for Children
Learn More & Join Trial